US Stock MarketDetailed Quotes

OVID Ovid Therapeutics

Watchlist
  • 0.746
  • -0.006-0.82%
Close Jul 5 16:00 ET
  • 0.750
  • +0.005+0.60%
Post 19:42 ET
52.89MMarket Cap-1035P/E (TTM)

About Ovid Therapeutics Company

Ovid Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of medicines for patients and families living with rare neurological disorders. The company was founded by Matthew During in April 2014 and is headquartered in New York, NY.

Company Profile

SymbolOVID
Company NameOvid Therapeutics
Listing DateMay 5, 2017
Issue Price15.00
Founded2014
CEOMr. Jeremy M. Levin, D.Phil.,M.B.
MarketNASDAQ
Employees40
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address441 9th Avenue,14th floor
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10001
Phone1-646-661-7661
Websitehttp://www.ovidrx.com

Company Executives

  • Name
  • Position
  • Salary
  • Jeremy M. Levin, D.Phil.,M.B.
  • Chairman of the Board, President and Chief Executive Officer
  • 2.14M
  • Jeffrey A. Rona
  • Principal Accounting Officer, Chief Business Officer and Chief Financial Officer
  • 1.08M
  • Dr. Robert Michael Poole, F.A.C.P.,M.D.
  • Independent Director
  • 79.16K
  • Barbara G. Duncan
  • Independent Director
  • 86.66K
  • Dr. Kevin Fitzgerald, PhD
  • Independent Director
  • 71.66K
  • Bart Friedman, J.D.
  • Lead Independent Director
  • 104.16K
  • Dr. Karen Bernstein, PhD
  • Independent Director
  • 91.66K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg